Showing 1 - 10 of 663,365
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10010510801
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10008697144
Persistent link: https://www.econbiz.de/10011377471
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10013316161
I model the market for an active ingredient (with a brand-name drug and n differentiated generic versions) to study the effect of a substitution rule on prices and the extensive and intensive margin of generic competition. Both substitution rules with physician and patient veto decrease the...
Persistent link: https://www.econbiz.de/10011986084
Persistent link: https://www.econbiz.de/10008655517
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …
Persistent link: https://www.econbiz.de/10009691207
Persistent link: https://www.econbiz.de/10009762378
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … generics and their market shares. In terms of policy implications, our results suggest that pharmacy incentives are crucial for …
Persistent link: https://www.econbiz.de/10013139185
version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …
Persistent link: https://www.econbiz.de/10013088216